OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Monoclonal antibodies in the management of asthma: Dead ends, current status and future perspectives
Grzegorz Kardas, Michał Panek, Piotr Kuna, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
Grzegorz Kardas, Michał Panek, Piotr Kuna, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
Biologics, theranostics, and personalized medicine in drug delivery systems
Matteo Puccetti, Marilena Pariano, Aurélie Schoubben, et al.
Pharmacological Research (2024) Vol. 201, pp. 107086-107086
Open Access | Times Cited: 62
Matteo Puccetti, Marilena Pariano, Aurélie Schoubben, et al.
Pharmacological Research (2024) Vol. 201, pp. 107086-107086
Open Access | Times Cited: 62
Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study
Angelantonio Maglio, Carolina Vitale, Corrado Pelaia, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2455-2455
Open Access | Times Cited: 34
Angelantonio Maglio, Carolina Vitale, Corrado Pelaia, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2455-2455
Open Access | Times Cited: 34
The Role of Eosinophil-Derived Neurotoxin and Vascular Endothelial Growth Factor in the Pathogenesis of Eosinophilic Asthma
Maciej Tota, Julia Łacwik, Julia Laska, et al.
Cells (2023) Vol. 12, Iss. 9, pp. 1326-1326
Open Access | Times Cited: 16
Maciej Tota, Julia Łacwik, Julia Laska, et al.
Cells (2023) Vol. 12, Iss. 9, pp. 1326-1326
Open Access | Times Cited: 16
Revisiting asthma pharmacotherapy: where do we stand and where do we want to go?
Mario Cazzola, Clive P. Page, Maria Gabriella Matera, et al.
European Respiratory Journal (2023) Vol. 62, Iss. 2, pp. 2300700-2300700
Closed Access | Times Cited: 16
Mario Cazzola, Clive P. Page, Maria Gabriella Matera, et al.
European Respiratory Journal (2023) Vol. 62, Iss. 2, pp. 2300700-2300700
Closed Access | Times Cited: 16
Thymic Stromal Lymphopoietin (TSLP), Its Isoforms and the Interplay with the Epithelium in Allergy and Asthma
Sylwia Smolińska, Darío Antolín‐Amérigo, Florin‐Dan Popescu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12725-12725
Open Access | Times Cited: 14
Sylwia Smolińska, Darío Antolín‐Amérigo, Florin‐Dan Popescu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12725-12725
Open Access | Times Cited: 14
Repositioning baloxavir marboxil as VISTA agonist that ameliorates experimental asthma
Jian-wen Di, Yixin Wang, Ruixue Ma, et al.
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 5
Jian-wen Di, Yixin Wang, Ruixue Ma, et al.
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 5
The potential role of nanobodies in asthma therapy
Baraa Khalid Salah Al-Sheakly, Fatemeh Saheb Sharif‐Askari, Narjes Saheb Sharif‐Askari, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Baraa Khalid Salah Al-Sheakly, Fatemeh Saheb Sharif‐Askari, Narjes Saheb Sharif‐Askari, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
WHAT WE KNOW TO DATE ABOUT EARLY TREATMENT WITH BIOLOGICS IN SEVERE ASTHMA
Luis Pérez de Llano, Mary Ann Bonilla, Elisa Luzón, et al.
Open Respiratory Archives (2025) Vol. 7, Iss. 2, pp. 100418-100418
Open Access
Luis Pérez de Llano, Mary Ann Bonilla, Elisa Luzón, et al.
Open Respiratory Archives (2025) Vol. 7, Iss. 2, pp. 100418-100418
Open Access
Dual biological treatments in immune-mediated disorders: a single center experience
Oded Shamriz, Elchanan Parnasa, Limor Rubin, et al.
BMC Immunology (2025) Vol. 26, Iss. 1
Open Access
Oded Shamriz, Elchanan Parnasa, Limor Rubin, et al.
BMC Immunology (2025) Vol. 26, Iss. 1
Open Access
Inhaled RNA drugs to treat lung diseases: Disease-related cells and nano–bio interactions
Mengjun Zhang, Haoyu Lu, Liangkun Xie, et al.
Advanced Drug Delivery Reviews (2023) Vol. 203, pp. 115144-115144
Closed Access | Times Cited: 12
Mengjun Zhang, Haoyu Lu, Liangkun Xie, et al.
Advanced Drug Delivery Reviews (2023) Vol. 203, pp. 115144-115144
Closed Access | Times Cited: 12
Asthma Biologics Across the T2 Spectrum of Inflammation in Severe Asthma: Biomarkers and Mechanism of Action
Andrew Lindsley, Njira Lugogo, Kaitlin A G Reeh, et al.
Journal of Asthma and Allergy (2025) Vol. Volume 18, pp. 33-57
Open Access
Andrew Lindsley, Njira Lugogo, Kaitlin A G Reeh, et al.
Journal of Asthma and Allergy (2025) Vol. Volume 18, pp. 33-57
Open Access
Endogenous and Exogenous Cytokines: An Overview and Introduction
Thomas R. Spitzer, Hillard M. Lazarus
Best Practice & Research Clinical Haematology (2025), pp. 101615-101615
Closed Access
Thomas R. Spitzer, Hillard M. Lazarus
Best Practice & Research Clinical Haematology (2025), pp. 101615-101615
Closed Access
Biologicals reduce drug burden and improve physical and mental health in severe eosinophilic asthma
Vincenzo Patella, Roberta Zunno, Girolamo Pelaia, et al.
Journal of Asthma (2025), pp. 1-6
Closed Access
Vincenzo Patella, Roberta Zunno, Girolamo Pelaia, et al.
Journal of Asthma (2025), pp. 1-6
Closed Access
Efficacy and Safety of Monoclonal Antibodies for the Treatment of Eosinophilic Esophagitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Fabiana Dolovitsch de Oliveira, Rodrigo Carvalho Costa, Emmily Daiane Buarque de Santana Sato, et al.
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 7, pp. 2530-2539
Closed Access | Times Cited: 3
Fabiana Dolovitsch de Oliveira, Rodrigo Carvalho Costa, Emmily Daiane Buarque de Santana Sato, et al.
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 7, pp. 2530-2539
Closed Access | Times Cited: 3
SANI clinical remission definition: a useful tool in severe asthma management
Giorgio Walter Canonica, Diego Bagnasco, Benedetta Bondi, et al.
Journal of Asthma (2024) Vol. 61, Iss. 12, pp. 1593-1600
Open Access | Times Cited: 3
Giorgio Walter Canonica, Diego Bagnasco, Benedetta Bondi, et al.
Journal of Asthma (2024) Vol. 61, Iss. 12, pp. 1593-1600
Open Access | Times Cited: 3
CAR-NKT Cells in Asthma: Use of NKT as a Promising Cell for CAR Therapy
Mohadeseh Mohammad Taheri, Fatemeh Javan, Mohadeseh Poudineh, et al.
Clinical Reviews in Allergy & Immunology (2024) Vol. 66, Iss. 3, pp. 328-362
Closed Access | Times Cited: 3
Mohadeseh Mohammad Taheri, Fatemeh Javan, Mohadeseh Poudineh, et al.
Clinical Reviews in Allergy & Immunology (2024) Vol. 66, Iss. 3, pp. 328-362
Closed Access | Times Cited: 3
Emerging applications and prospects of NFκB decoy oligodeoxynucleotides in managing respiratory diseases
Jessica Katrine Datsyuk, Keshav Raj Paudel, Rashi Rajput, et al.
Chemico-Biological Interactions (2023) Vol. 385, pp. 110737-110737
Open Access | Times Cited: 7
Jessica Katrine Datsyuk, Keshav Raj Paudel, Rashi Rajput, et al.
Chemico-Biological Interactions (2023) Vol. 385, pp. 110737-110737
Open Access | Times Cited: 7
Baseline Characteristics of Patients Enrolled in Clinical Trials of Biologics for Severe Asthma as Potential Predictors of Outcomes
Francesco Menzella
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1546-1546
Open Access | Times Cited: 6
Francesco Menzella
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1546-1546
Open Access | Times Cited: 6
Emerging role for interferons in respiratory viral infections and childhood asthma
Anthony Bosco
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Anthony Bosco
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
New targets for type 2-low asthma
Quang Luu Quoc, Youngwoo Choi, Gyu-Young Hur, et al.
The Korean Journal of Internal Medicine (2024) Vol. 39, Iss. 2, pp. 215-227
Open Access | Times Cited: 1
Quang Luu Quoc, Youngwoo Choi, Gyu-Young Hur, et al.
The Korean Journal of Internal Medicine (2024) Vol. 39, Iss. 2, pp. 215-227
Open Access | Times Cited: 1
Potential of MAIT cells to modulate asthma
Yasuo Shimizu, Chie Sugimoto, Hiroshi Wakao
Allergology International (2023) Vol. 73, Iss. 1, pp. 40-47
Open Access | Times Cited: 3
Yasuo Shimizu, Chie Sugimoto, Hiroshi Wakao
Allergology International (2023) Vol. 73, Iss. 1, pp. 40-47
Open Access | Times Cited: 3
CAR T Cells for Treating Severe Atopic Allergic Diseases
Ronald P. Dudek, Zhengyu Ma
Delaware Journal of Public Health (2023) Vol. 9, Iss. 4, pp. 12-15
Open Access | Times Cited: 3
Ronald P. Dudek, Zhengyu Ma
Delaware Journal of Public Health (2023) Vol. 9, Iss. 4, pp. 12-15
Open Access | Times Cited: 3
The effect of Bruton’s tyrosine kinase (BTK) inhibitor in the eosinophilic asthma model of mouse
Y. S. Choi, Seo-Hee Kim, Seung Jun Shin, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111903-111903
Closed Access
Y. S. Choi, Seo-Hee Kim, Seung Jun Shin, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111903-111903
Closed Access
Immunogenicity of biologics used in the treatment of asthma
Omario A.M. Neunie, Wardah Rabbani, David Baker, et al.
Human Antibodies (2024) Vol. 32, Iss. 3, pp. 121-128
Closed Access
Omario A.M. Neunie, Wardah Rabbani, David Baker, et al.
Human Antibodies (2024) Vol. 32, Iss. 3, pp. 121-128
Closed Access
Characterizing the Asthma Phenotype of Military Personnel
Joshua Boster, William J Moore, STEVEN STOFFEL, et al.
Military Medicine (2024) Vol. 189, Iss. Supplement_3, pp. 137-141
Open Access
Joshua Boster, William J Moore, STEVEN STOFFEL, et al.
Military Medicine (2024) Vol. 189, Iss. Supplement_3, pp. 137-141
Open Access
